The Enterprise Value as of September 2024 (TTM) for IVERIC bio, Inc. (ISEE) is 5.14B

According to IVERIC bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.14B. This represents a change of 146.71% compared to the average of 2.08B of the last 4 quarters.

IVERIC bio, Inc. (ISEE) Historical Enterprise Value (quarterly & annually)

How has ISEE Enterprise Value performed in the past?

The mean historical Enterprise Value of IVERIC bio, Inc. over the last ten years is 826.23M. The current 5.14B Enterprise Value has changed 62.14% with respect to the historical average. Over the past ten years (40 quarters), ISEE's Enterprise Value was at its highest in in the March 2023 quarter at 2.97B. The Enterprise Value was at its lowest in in the September 2013 quarter at -182749550.00.

IVERIC bio, Inc. (ISEE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IVERIC bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IVERIC bio, Inc. (ISEE) Average Enterprise Value

How has ISEE Enterprise Value performed in the past?

The current Enterprise Value of IVERIC bio, Inc. (ISEE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IVERIC bio, Inc. (ISEE) Enterprise Value vs. Peers

How is ISEE’s Enterprise Value compared to its peers?

IVERIC bio, Inc.’s Enterprise Value is less than Blueprint Medicines Corporation (6.16B), greater than Amylyx Pharmaceuticals, Inc. (89.50M), less than Karuna Therapeutics, Inc. (12.43B), greater than Day One Biopharmaceuticals, Inc. (1.01B), greater than Immunovant, Inc. (4.42B), greater than Akero Therapeutics, Inc. (1.56B), greater than Madrigal Pharmaceuticals, Inc. (4.91B), greater than Apellis Pharmaceuticals, Inc. (5.11B), greater than 89bio, Inc. (712.19M), greater than Pliant Therapeutics, Inc. (762.35M), greater than Arcellx, Inc. (3.80B), greater than Stoke Therapeutics, Inc. (586.20M), greater than Roivant Sciences Ltd. (3.79B), greater than Krystal Biotech, Inc. (4.95B), less than Prometheus Biosciences, Inc. (9.47B), less than Viking Therapeutics, Inc. (5.95B), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than Terns Pharmaceuticals, Inc. (458.36M), less than Reata Pharmaceuticals, Inc. (6.68B),

Build a custom stock screener for IVERIC bio, Inc. (ISEE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IVERIC bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IVERIC bio, Inc. (ISEE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IVERIC bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.